PREVALENCE, CLINICAL MANIFESTATIONS, AND ASSOCIATED FACTORS OF LONG COVID-19

Rojas-Bolivar D.; Huaroto-Ramírez F.; Curisinche-Rojas M.; Zurita D.G.; Gutiérrez E. · Revista de la Facultad de Medicina Humana (2022) · DOI: 10.25176/rfmh.v22i3.5009

Resumen

Objective: The objective was to describe the prevalence, clinical manifestations, and associated factors of long COVID-19. Methods: A bibliographic search of systematic reviews and meta-analyses on long COVID-19 was carried out in MEDLINE (via PubMed) up to April 7th, 2022. 37 articles were found and 3 were included. Results: The quality of the evidence was evaluated through AMSTAR 2 criteria. The reported prevalence of long COVID- 19 was 43% (95% CI: 39% - 46%). The main clinical manifestations were weakness (41% [95% CI: 25% - 59%]), malaise (33% [95% CI: 15% - 57%]), fatigue (31% [95% CI: 24% - 39% %]), changes in concentration (26% [95% CI: 21% - 32%]) and shortness of breath (25% [95% CI: 18% - 34%]). Conclusion: Factors associated with long COVID-19 include female gender, the severity of initial symptoms, age, and the presence of comorbidities.

Instituciones: Universidad Ricardo Palma